Pharmacovigilance

Mexico Regulatory authority update

COFEPRIS, the Mexico regulatory authority, has mandated to transmit WHODrug Medicinal Product ID (MPID) and WHODrug Version in the E2B R3 report from 1 Jan 2024. This is to be used in pre-marketed and post-marketed cases – all drugs/vaccines (Suspect / Concomitant / Interacting / Historical Drugs).

Click to access Planteamiento_para_WHODrug_1.1_21-03-2023_version_ingles.pdf

Click to access Anexo_2._How_to_use_the_WHODrug_C3_format_for_drug_coding.pdf

The WHO MPID and WHODrug Version need to be transmitted in the following elements in the specified format and Code System Object Identifier (OID):

Reference: https://support.oracle.com/knowledge/More%20Applications%20and%20Technologies/2965643_1.html

Posted

in

by

Ramya

Tags:

Comments

2 responses to “Mexico Regulatory authority update”

  1. Dana Grant Avatar
    Dana Grant

    Your detailed analysis is what sets your blog apart from others.

    Reply
  2. Avatar
    Anonymous

    Hi i am Venkata Panchumarthi.
    Awesome. This article is very nice and it gives lot of information. I read the excellent article in recent days its helped me a lot. Thanks for sharing such a nice article.

    Reply

Leave a Reply

error: Content is protected !!